David Fisher
Director/Board Member bei NANOSONICS LIMITED
Vermögen: 545 299 $ am 31.03.2024
Profil
David M.
Fisher is currently serving as an Independent Non-Executive Director at Nanosonics Ltd.
He is also a Director at Australian Biotechnology & Healthcare Fund.
No.
3 Ltd., Australian Biomedical Fund No.
1 Ltd., Australian Biomedical Fund No.
2 Ltd., and a Venture Partner at Brandon Capital Partners Pty Ltd.
Additionally, he is a Member of AusBiotech Ltd.
In his former roles, Dr. Fisher served as the Chief Executive Officer of Arana Therapeutics Ltd.
and GI Therapies Pty Ltd.
He was also a Non-Executive Director at Aeris Environmental Ltd.
from 2013 to 2014, and a Non-Executive Director at Signostics Ltd.
He served as a Director at Global Kinetics Pty Ltd.Dr. Fisher obtained his undergraduate and doctorate degrees from The University of Sydney.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
NANOSONICS LIMITED
0,10% | 30.06.2023 | 303 940 ( 0,10% ) | 545 299 $ | 31.03.2024 |
Aktive Positionen von David Fisher
| Unternehmen | Position | Beginn |
|---|---|---|
| NANOSONICS LIMITED | Director/Board Member | 27.07.2009 |
Australian Biomedical Fund No. 1 Ltd.
 Australian Biomedical Fund No. 1 Ltd. Investment ManagersFinance Australian Biomedical Fund No. 1 Ltd. invests in emerging life sciences companies located in Australia. The fund focuses on biotechnology & healthcare companies operating in the fields of pharmaceutical products & services, medical devices, e-commerce applications and computer software. It provides financing for start ups and early stage capital requirements. It also considers co-investments with other funds or private investors. | Director/Board Member | - |
Australian Biomedical Fund No. 2 Ltd.
 Australian Biomedical Fund No. 2 Ltd. Investment ManagersFinance Australian Biomedical Fund No. 2 Ltd. invests in emerging life sciences companies located in Australia. The fund focuses on biotechnology & healthcare companies operating in the fields of pharmaceutical products & services, medical devices, e-commerce applications and computer software. It provides financing for start ups and early stage capital requirements. It also considers co-investments with other funds or private investors. | Director/Board Member | - |
Australian Biotechnology & Healthcare Fund No. 3 Ltd.
 Australian Biotechnology & Healthcare Fund No. 3 Ltd. Investment ManagersFinance Australian Biotechnology & Healthcare Fund No. 3 Ltd. invests in emerging life sciences companies located in Australia. The fund focuses on biotechnology & healthcare companies operating in the fields of pharmaceutical products & services, medical devices, e-commerce applications and computer software. It provides financing for start ups and early stage capital requirements. It also considers co-investments with other funds or private investors. | Director/Board Member | - |
AusBiotech Ltd.
 AusBiotech Ltd. Miscellaneous Commercial ServicesCommercial Services AusBiotech Ltd. operates as an Australian biotechnology membership company. The private company is based in Melbourne, Australia. and has subsidiaries in Australia. The company was founded by Liz Dallimore. Lorraine Chiroiu has been the CEO of the company since 2008. | Corporate Officer/Principal | - |
Brandon Capital Partners Pty Ltd.
 Brandon Capital Partners Pty Ltd. Investment ManagersFinance Brandon Capital Partners Pty Ltd. (Brandon Capital Partners) is a venture capital firm founded in 2007 by David Fisher and Chris Nave. The firm is headquartered in Sydney, Australia. | Private Equity Investor | 01.09.2006 |
Ehemalige bekannte Positionen von David Fisher
| Unternehmen | Position | Ende |
|---|---|---|
| AERIS ENVIRONMENTAL LTD | President | 29.03.2013 |
GI Therapies Pty Ltd.
 GI Therapies Pty Ltd. Medical SpecialtiesHealth Technology GI Therapies Pty Ltd. designs and develops medical devices for the treatment of chronic constipation. It offers technology to treat gastrointestinal motility disorders, including chronic constipation, irritable bowel syndrome with constipation and gastroparesis. The company was founded in 2012 and is headquartered in Melbourne, Australia. | Chief Executive Officer | - |
Global Kinetics Pty Ltd.
 Global Kinetics Pty Ltd. Medical SpecialtiesHealth Technology Global Kinetics Pty Ltd. provides point of care measurement and reporting of Parkinson's disease motor symptoms. Its product includes Personal KinetiGraph (PKG), a wrist worn medical device which reminds the patient when they have taken Levodopa medication as prescribed by doctor. The company was founded by Robert Griffiths and Malcolm Horne in 2007 and is headquartered in Melbourne, Australia. | Director/Board Member | - |
| ░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - |
| ░░░░░ ░░░░░░░░░░░░ ░░░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | - |
Ausbildung von David Fisher
| The University of Sydney | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| NANOSONICS LIMITED | Health Technology |
| AERIS ENVIRONMENTAL LTD | Consumer Non-Durables |
| Private Unternehmen | 9 |
|---|---|
Arana Therapeutics Ltd.
 Arana Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Arana Therapeutics Ltd. engages in researching and developing, investing, licensing, technology, producing, formulating and marketing peptides and related products for the human and animal pharmaceutical industries. It develops and provides human therapeutic products for the treatment of diseases in the areas of cancer and inflammation and products for fertility control in animals. The company was founded in 1985 and is headquartered in Macquarie Park, Australia. | Health Technology |
Australian Biotechnology & Healthcare Fund No. 3 Ltd.
Australian Biotechnology & Healthcare Fund No. 3 Ltd. Investment ManagersFinance Australian Biotechnology & Healthcare Fund No. 3 Ltd. invests in emerging life sciences companies located in Australia. The fund focuses on biotechnology & healthcare companies operating in the fields of pharmaceutical products & services, medical devices, e-commerce applications and computer software. It provides financing for start ups and early stage capital requirements. It also considers co-investments with other funds or private investors. | Finance |
Australian Biomedical Fund No. 1 Ltd.
Australian Biomedical Fund No. 1 Ltd. Investment ManagersFinance Australian Biomedical Fund No. 1 Ltd. invests in emerging life sciences companies located in Australia. The fund focuses on biotechnology & healthcare companies operating in the fields of pharmaceutical products & services, medical devices, e-commerce applications and computer software. It provides financing for start ups and early stage capital requirements. It also considers co-investments with other funds or private investors. | Finance |
Australian Biomedical Fund No. 2 Ltd.
Australian Biomedical Fund No. 2 Ltd. Investment ManagersFinance Australian Biomedical Fund No. 2 Ltd. invests in emerging life sciences companies located in Australia. The fund focuses on biotechnology & healthcare companies operating in the fields of pharmaceutical products & services, medical devices, e-commerce applications and computer software. It provides financing for start ups and early stage capital requirements. It also considers co-investments with other funds or private investors. | Finance |
Brandon Capital Partners Pty Ltd.
Brandon Capital Partners Pty Ltd. Investment ManagersFinance Brandon Capital Partners Pty Ltd. (Brandon Capital Partners) is a venture capital firm founded in 2007 by David Fisher and Chris Nave. The firm is headquartered in Sydney, Australia. | Finance |
Signostics Ltd.
 Signostics Ltd. Medical SpecialtiesHealth Technology Signostics Ltd. provides ultrasound devices. It offers Uscan and Signosrt Handheld Ultrasound scanner. The company was founded by Neil Bartlett and Stewart Bartlett in 2005 and is headquartered in Adelaide, Australia. | Health Technology |
AusBiotech Ltd.
AusBiotech Ltd. Miscellaneous Commercial ServicesCommercial Services AusBiotech Ltd. operates as an Australian biotechnology membership company. The private company is based in Melbourne, Australia. and has subsidiaries in Australia. The company was founded by Liz Dallimore. Lorraine Chiroiu has been the CEO of the company since 2008. | Commercial Services |
Global Kinetics Pty Ltd.
Global Kinetics Pty Ltd. Medical SpecialtiesHealth Technology Global Kinetics Pty Ltd. provides point of care measurement and reporting of Parkinson's disease motor symptoms. Its product includes Personal KinetiGraph (PKG), a wrist worn medical device which reminds the patient when they have taken Levodopa medication as prescribed by doctor. The company was founded by Robert Griffiths and Malcolm Horne in 2007 and is headquartered in Melbourne, Australia. | Health Technology |
GI Therapies Pty Ltd.
GI Therapies Pty Ltd. Medical SpecialtiesHealth Technology GI Therapies Pty Ltd. designs and develops medical devices for the treatment of chronic constipation. It offers technology to treat gastrointestinal motility disorders, including chronic constipation, irritable bowel syndrome with constipation and gastroparesis. The company was founded in 2012 and is headquartered in Melbourne, Australia. | Health Technology |
